Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Assessing the effect of global travel and contact reductions to mitigate the COVID-19 pandemic and resurgence

View ORCID ProfileShengjie Lai, Nick W Ruktanonchai, Alessandra Carioli, Corrine W Ruktanonchai, Jessica R Floyd, Olivia Prosper, Chi Zhang, Xiangjun Du, Weizhong Yang, Andrew J Tatem
doi: https://doi.org/10.1101/2020.06.17.20133843
Shengjie Lai
1WorldPop, School of Geography and Environmental Science, University of Southampton, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shengjie Lai
  • For correspondence: Shengjie.Lai@soton.ac.uk nr1e14@soton.ac.uk A.J.Tatem@soton.ac.uk
Nick W Ruktanonchai
1WorldPop, School of Geography and Environmental Science, University of Southampton, UK
2Population Health Sciences, Virginia Tech, Blacksburg, VA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Shengjie.Lai@soton.ac.uk nr1e14@soton.ac.uk A.J.Tatem@soton.ac.uk
Alessandra Carioli
1WorldPop, School of Geography and Environmental Science, University of Southampton, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corrine W Ruktanonchai
1WorldPop, School of Geography and Environmental Science, University of Southampton, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica R Floyd
1WorldPop, School of Geography and Environmental Science, University of Southampton, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivia Prosper
3Department of Mathematics, University of Tennessee, Knoxville, TN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chi Zhang
4School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiangjun Du
4School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weizhong Yang
5Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew J Tatem
1WorldPop, School of Geography and Environmental Science, University of Southampton, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Shengjie.Lai@soton.ac.uk nr1e14@soton.ac.uk A.J.Tatem@soton.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Travel and physical distancing interventions have been implemented across the World to mitigate the COVID-19 pandemic, but studies are needed to quantify the effectiveness of these measures across regions and time. Timely population mobility data were obtained to measure travel and contact reductions in 135 countries or territories. During the 10 weeks of March 22 – May 30, 2020, domestic travel in study regions has dramatically reduced to a median of 59% (interquartile range [IQR] 43% - 73%) of normal levels seen before the outbreak, with international travel down to 26% (IQR 12% - 35%). If these travel and physical distancing interventions had not been deployed across the World, the cumulative number of cases might have shown a 97-fold (IQR 79 – 116) increase, as of May 31, 2020. However, effectiveness differed by the duration and intensity of interventions and relaxation scenarios, with variations in case severity seen across populations, regions, and seasons.

One Sentence Summary Travel and physical distancing interventions across the World are key to mitigate the COVID-19 pandemic and resurgence.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by the grants from the Bill & Melinda Gates Foundation (OPP1134076); the European Union Horizon 2020 (MOOD 874850). N.R. is supported by funding from the Bill & Melinda Gates Foundation (OPP1170969). O.P. is supported by the National Science Foundation (1816075). A.J.T. is supported by funding from the Bill & Melinda Gates Foundation (OPP1106427, OPP1032350, OPP1134076, OPP1094793), the Clinton Health Access Initiative, the UK Department for International Development (DFID) and the Wellcome Trust (106866/Z/15/Z, 204613/Z/16/Z).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical clearance for collecting and using secondary population mobility data was granted by the institutional review board of the University of Southampton (No. 48002). All data were supplied and analyzed in an anonymous format, without access to personal identifying information.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Code for the model simulations is available at the following GitHub repository: https://github.com/wpgp/BEARmod. The data on COVID-19 cases and interventions reported by country are available from the data sources listed in Supplementary Materials. The parameters and population data for running simulations and estimating the severity are listed in Supplementary Data S1 to S2. The population movement data obtained from Baidu are available at: https://qianxi.baidu.com/. The Google COVID-19 Aggregated Mobility Research Dataset used for this study is available with permission of Google, LLC.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 19, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Assessing the effect of global travel and contact reductions to mitigate the COVID-19 pandemic and resurgence
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Assessing the effect of global travel and contact reductions to mitigate the COVID-19 pandemic and resurgence
Shengjie Lai, Nick W Ruktanonchai, Alessandra Carioli, Corrine W Ruktanonchai, Jessica R Floyd, Olivia Prosper, Chi Zhang, Xiangjun Du, Weizhong Yang, Andrew J Tatem
medRxiv 2020.06.17.20133843; doi: https://doi.org/10.1101/2020.06.17.20133843
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Assessing the effect of global travel and contact reductions to mitigate the COVID-19 pandemic and resurgence
Shengjie Lai, Nick W Ruktanonchai, Alessandra Carioli, Corrine W Ruktanonchai, Jessica R Floyd, Olivia Prosper, Chi Zhang, Xiangjun Du, Weizhong Yang, Andrew J Tatem
medRxiv 2020.06.17.20133843; doi: https://doi.org/10.1101/2020.06.17.20133843

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (431)
  • Anesthesia (99)
  • Cardiovascular Medicine (940)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (418)
  • Epidemiology (8967)
  • Forensic Medicine (4)
  • Gastroenterology (417)
  • Genetic and Genomic Medicine (1938)
  • Geriatric Medicine (190)
  • Health Economics (400)
  • Health Informatics (1320)
  • Health Policy (657)
  • Health Systems and Quality Improvement (517)
  • Hematology (211)
  • HIV/AIDS (416)
  • Infectious Diseases (except HIV/AIDS) (10764)
  • Intensive Care and Critical Care Medicine (570)
  • Medical Education (199)
  • Medical Ethics (52)
  • Nephrology (221)
  • Neurology (1815)
  • Nursing (108)
  • Nutrition (271)
  • Obstetrics and Gynecology (351)
  • Occupational and Environmental Health (469)
  • Oncology (992)
  • Ophthalmology (296)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (576)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1891)
  • Public and Global Health (4107)
  • Radiology and Imaging (674)
  • Rehabilitation Medicine and Physical Therapy (361)
  • Respiratory Medicine (547)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (206)
  • Toxicology (38)
  • Transplantation (109)
  • Urology (80)